Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
Active, not recruiting · NCT05645380 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Active, not recruiting | Phase 2 | 2026-04-28 | NCT05645380 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Kansas Medical Center | 169 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of Kansas Cancer Center - Clinical Research Center | Fairway | United States | 1 |
| The University of Kansas Cancer Center - Lee's Summit | Lee's Summit | United States | 6 |
| The University of Kansas Cancer Center - Main Hospital | Kansas City | United States | 1 |
| The University of Kansas Cancer Center - North | Kansas City | United States | 4 |
| The University of Kansas Cancer Center - Overland Park | Overland Park | United States | 6 |
| The University of Kansas Cancer Center - Westwood | Kansas City | United States | 3 |
| University of Kansas Cancer Center at North Kansas City Hospital | North Kansas City | United States | 91 |